Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV

Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV

BackgroundThe initiation of antiretroviral treatment based on a 2-drug regimen (2DR) with dolutegravir plus lamivudine has demonstrated non-inferior efficacy than dolutegravir-based three-drug regimens (3DR). We aimed to assess whether the treatment initiation with this 2DR has a different impact on...

Full description

Bibliographic Details
Main Authors: Javier Martínez-Sanz, Raquel Ron, Elena Moreno, Matilde Sánchez-Conde, Alfonso Muriel, Luis Fernando López Cortés, José Ramón Blanco, Juan Antonio Pineda, Álvaro Mena, Sonia Calzado Isbert, Santiago Moreno, Sergio Serrano-Villar
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Immunology
Subjects:
HIV
antiretroviral therapy
dual therapy
CD4/CD8 ratio
integrase inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.873408/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.873408/full

Similar Items